Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia

Annals of General Psychiatry

Volumn 10, Issue , 2011, Pages

  Sugawara, Norio ^a,b   Yasui Furukori, Norio ^b   Sato, Yasushi ^a,b   Kishida, Ikuko ^c,d   Yamashita, Hakuei ^e,f   Saito, Manabu ^b   Furukori, Hanako ^g   Nakagami, Taku ^b,h   Hatakeyama, Mitsunori ⁱ   Kaneko, Sunao ^b  

^a Hirosaki Aiseikai Hospital   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c Fujisawa City Hospital   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e Moro Hospital   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

^g Kuroishi General Hospital   (Japan)

^h Odate Municipal Hospital   (Japan)

ⁱ Department of Psychiatry   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; HOSPITAL CARE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; MENTAL PATIENT; METABOLIC SYNDROME X; OUTPATIENT CARE; PREVALENCE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 80052578543     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-10-21     Document Type: Article

References (27)

1. Cohn T, Prud'homme D, Streiner D, Kameh H, Remington G. Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can J Psychiatry 2004, 49:753-760.
2. Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, Patel JK, Keefe RS, Stroup TS, Lieberman JA. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res 2005, 80:9-18. 10.1016/j.schres.2005.07.015, 16125372.
3. Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M, Rejas J. CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS study. Schizophr Res 2007, 90:162-173. 10.1016/j.schres.2006.09.025, 17123783.
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689. 10.2337/diacare.24.4.683, 11315831.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716. 10.1001/jama.288.21.2709, 12460094.
6. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112:3066-3072. 10.1161/CIRCULATIONAHA.105.539528, 16275870.
7. Expert Panel on Detection, Evaluation and Treatmentof High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702, Expert Panel on Detection, Evaluation and Treatmentof High Blood Cholesterol in Adults.
8. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999, 83:25F-29F.
9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
10. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480. 10.1111/j.1464-5491.2006.01858.x, 16681555.
11. Lear SA, Toma M, Birmingham CL, Frohlich JJ. Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. Metabolism 2003, 52:1295-1301. 10.1016/S0026-0495(03)00196-3, 14564681.
12. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 2004, 27:1182-1186. 10.2337/diacare.27.5.1182, 15111542.
13. International Diabetes Federation The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation., http://www.idf.org/webdata/docs/MetSyndrome_FINAL.pdf
14. Examination Committee of the Criteria for Metabolic Syndrome in Japan Definition and criteria of the metabolic syndrome in Japan [in Japanese]. Japan Intern Med 2005, 94:188-201. Examination Committee of the Criteria for Metabolic Syndrome in Japan.
15. Examination Committee of the Criteria for "Obesity Disease" in Japan, Japan Society for the study of Obesity New criteria for 'obesity disease' in Japan. Circ J 2002, 66:987-992. 10.1253/circj.66.987, 12419927, Examination Committee of the Criteria for "Obesity Disease" in Japan, Japan Society for the study of Obesity.
16. Lee JS, Kawakubo K, Mori K, Akabayashi A. Effective cut-off values of waist circumference to detect the clustering of cardiovascular risk factors of metabolic syndrome in Japanese men and women. Diab Vasc Dis Res 2007, 4:340-345. 10.3132/dvdr.2007.062, 18158705.
17. Oshima I, Mino Y, Inomata Y. How many long-stay schizophrenia patients can be discharged in Japan?. Psychiatry Clin Neurosci 2007, 61:71-77. 10.1111/j.1440-1819.2007.01613.x, 17239042.
18. Statistics and Information Department Minister's Secretariat, Ministry of Health, Labour and Welfare Patient Survey 2008, Tokyo, Japan: Ministry of Health, Labour and Welfare, Statistics and Information Department Minister's Secretariat, Ministry of Health, Labour and Welfare.
19. Sugawara N, Yasui-Furukori N, Sato Y, Umeda T, Kishida I, Yamashita H, Saito M, Furukori H, Nakagami T, Hatakeyama M, Nakaji S, Kaneko S. Prevalence of metabolic syndrome among patients with schizophrenia in Japan. Schizophr Res 2010, 123:244-250. 10.1016/j.schres.2010.08.030, 20850274.
20. Rezaei O, Khodaie-Ardakani MR, Mandegar MH, Dogmehchi E, Goodarzynejad H. Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia. Int J Psychiatry Med 2009, 39:451-462. 10.2190/PM.39.4.i, 20391865.
21. Teixeira PJ, Rocha FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 2007, 29:330-336.
22. Huang MC, Lu ML, Tsai CJ, Chen PY, Chiu CC, Jian DL, Lin KM, Chen CH. Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan. Acta Psychiatr Scand 2009, 120:274-280. 10.1111/j.1600-0447.2009.01401.x, 19426161.
23. Takahashi S, Matsuura M, Tanabe E, Yara K, Nonaka K, Fukura Y, Kikuchi M, Kojima T. Age at onset of schizophrenia: gender differences and influence of temporal socioeconomic change. Psychiatry Clin Neurosci 2000, 54:153-156. 10.1046/j.1440-1819.2000.00651.x, 10803808.
24. Tang YL, Gillespie CF, Epstein MP, Mao PX, Jiang F, Chen Q, Cai ZJ, Mitchell PB. Gender differences in 542 Chinese inpatients with schizophrenia. Schizophr Res 2007, 97:88-96. 10.1016/j.schres.2007.05.025, 17628430.
25. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry 2004, 65:471-477.
26. Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctôt G, Saindon J, Vincent A, Gagnon S, Tremblay A. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry 2007, 41:980-989. 10.1080/00048670701689428, 17999270.
27. Fernandez-Egea E, Bernardo M, Donner T, Conget I, Parellada E, Justicia A, Esmatjes E, Garcia-Rizo C, Kirkpatrick B. Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry 2009, 194:434-438. 10.1192/bjp.bp.108.052605, 2703813,2703813, 19407273.